Prevalence of glucose 6-phosphate dehydrogenase deficiency in highly malaria-endemic municipalities in the Brazilian Amazon: A region-wide screening study
暂无分享,去创建一个
Q. Bassat | W. Monteiro | V. Sampaio | M. Lacerda | J. D. Brito-Sousa | D. Baía-da-Silva | G. Melo | E. F. Figueiredo | A. Almeida | M. Costa | Laila R A Barbosa | A. Silva-Neto | J. Nascimento | E. Silva | P. Balieiro | Marly M Melo | Reinaldo Nery Ramos | Gustavo Romero
[1] W. Monteiro,et al. Real-life quantitative G6PD screening in Plasmodium vivax patients in the Brazilian Amazon: A cost-effectiveness analysis , 2022, PLoS neglected tropical diseases.
[2] W. Monteiro,et al. Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil , 2021, PLoS neglected tropical diseases.
[3] W. Monteiro,et al. Short-Time Recurrences of Plasmodium vivax Malaria as a Public Health Proxy for Chloroquine-Resistance Surveillance: A Spatio-Temporal Study in the Brazilian Amazon , 2021, International journal of environmental research and public health.
[4] Q. Bassat,et al. Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study) , 2021, PLoS neglected tropical diseases.
[5] W. Monteiro,et al. Perceptions about malaria among Brazilian gold miners in an Amazonian border area: perspectives for malaria elimination strategies , 2021, Malaria journal.
[6] R. Price,et al. Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case–control data from Bangladesh , 2021, PLoS medicine.
[7] R. Price,et al. Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis , 2019, PLoS medicine.
[8] Q. Bassat,et al. Tafenoquine for the prophylaxis, treatment and elimination of malaria: eagerness must meet prudence. , 2019, Future microbiology.
[9] Q. Bassat,et al. Clinical Spectrum of Primaquine-induced Hemolysis in G6PD Deficiency: A Nine-Year Hospitalization-Based Study from the Brazilian Amazon. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] J. Baird,et al. Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency , 2019, The Journal of infectious diseases.
[11] W. Monteiro,et al. Misperceptions of patients and health workers regarding malaria elimination in the Brazilian Amazon: a qualitative study , 2019, Malaria Journal.
[12] W. Monteiro,et al. Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria , 2019, The New England journal of medicine.
[13] F. Nosten,et al. Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient , 2018, The American journal of tropical medicine and hygiene.
[14] E. Ashley,et al. Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries , 2018, PLoS neglected tropical diseases.
[15] F. Nosten,et al. Primaquine-induced haemolysis in females heterozygous for G6PD deficiency , 2018, Malaria Journal.
[16] W. Monteiro,et al. CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study , 2018, Malaria Journal.
[17] N. White,et al. Modelling primaquine-induced haemolysis in G6PD deficiency , 2017, eLife.
[18] H. Win,et al. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens , 2017, PLoS medicine.
[19] Q. Bassat,et al. Fatal Primaquine-Induced Hemolysis in a Patient With Plasmodium vivax Malaria and G6PD A(-) Variant in the Brazilian Amazon. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] M. R. F. de Oliveira,et al. G6PD deficiency in male individuals infected by Plasmodium vivax malaria in the Brazilian Amazon: a cost study , 2015, Malaria Journal.
[21] Q. Bassat,et al. G6PD deficiency in Latin America: systematic review on prevalence and variants , 2014, Memorias do Instituto Oswaldo Cruz.
[22] W. Monteiro,et al. High frequency of diabetes and impaired fasting glucose in patients with glucose-6-phosphate dehydrogenase deficiency in the Western brazilian Amazon. , 2014, The American journal of tropical medicine and hygiene.
[23] T. Slusher,et al. PCR-Based Allelic Discrimination for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in Ugandan Umbilical Cord Blood , 2014, Pediatric hematology and oncology.
[24] Q. Bassat,et al. Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes , 2014, Malaria Journal.
[25] Q. Cheng,et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests , 2013, Malaria Journal.
[26] W. Monteiro,et al. Glucose-6-phosphate dehydrogenase deficient variants are associated with reduced susceptibility to malaria in the Brazilian Amazon. , 2013, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[27] S. Hay,et al. G6PD deficiency: global distribution, genetic variants and primaquine therapy. , 2013, Advances in parasitology.
[28] Q. Cheng,et al. PD testing in support of treatment and elimination of malaria : recommendations for evaluation of G 6 PD tests , 2013 .
[29] Anand P. Patil,et al. G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map , 2012, PLoS medicine.
[30] Q. Bassat,et al. Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] E. Capoluongo,et al. Glucose‐6‐phosphate dehydrogenase laboratory assay: How, when, and why? , 2009, IUBMB life.
[32] M. Cappellini,et al. Glucose-6-phosphate dehydrogenase deficiency , 2008, The Lancet.
[33] J. Bautista,et al. G6PD deficiency: the genotype-phenotype association. , 2007, Blood reviews.
[34] L. Luzzatto. Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype. , 2006, Haematologica.